Search Result "serum atherogenicity"


Blood Serum Atherogenicity and Coronary Artery Calcification

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5884-5888
Author(s): Igor A. Sobenin, Veronica A. Myasoedova, Elena V. Anisimova, Xenia N. Pavlova, Stefan Mohlenkamp, Axel Schmermund, Rainer Seibel, Sina Berenbein, Nils Lehmann, Susanne Moebus, KarlHeinz Jockel, Alexander N. Orekhov, Raimund Erbel

Review Article

Blood Serum Atherogenicity: Cellular Test for the Development of Anti- Atherosclerotic Therapy

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 8 Year: 2017 Page: 1195-1206
Author(s): Veronika A. Myasoedova,Galina A. Ivashinnikova,Igor A. Sobenin,Ekaterina A. Ivanova,Alexander N. Orekhov

Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5954-5962
Author(s): Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov, Alexander N. Orekhov

Research Article

Elevated Serum Levels of Ischemia Modified Albumin and Malondialdehyde are Related to Atherogenic Index of Plasma in a Cohort of Prediabetes

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 8 Year: 2020 Page: 1347-1354
Author(s): Mervat M. El-Eshmawy,Doaa F. Gad,Azza A. El-Baiomy

The Anti-Atherogenic Effects of Thiazolidinediones

Journal: Current Diabetes Reviews
Volume: 3 Issue: 1 Year: 2007 Page: 67-74
Author(s): Lily Stojanovska, Suzy Y. Honisett, Paul A. Komesaroff

Research Article

Novel Monocyte Biomarkers of Atherogenic Conditions

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5859-5864
Author(s): Alexei Gratchev, Ilja Ovsiy, Ioannis Manousaridis, Vladimir Riabov, Alexander Orekhov, Julia Kzhyshkowska

The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?

Journal: Current Drug Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 177-195
Author(s): Giovanni Anfossi, Mariella Trovati

“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos

Anti-Atherogenic Role of Peroxisome Proliferator-Activated Receptor Ligands

Journal: Current Cardiology Reviews
Volume: 1 Issue: 2 Year: 2005 Page: 89-102
Author(s): Julie Nigro, Mandy L. Ballinger, Narin Osman, Anthony M. Dart, Peter J. Little

Cross-talk Between Exogenous Statins and Endogenous High-Density Lipoprotein in Anti-Inflammatory and Anti-Atherogenic Actions

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 1 Year: 2010 Page: 8-15
Author(s): Takao Kimura, Koichi Sato, Hideaki Tomura, Fumikazu Okajima

Previous   Next

Go To   Results 1 - 1 of 1596

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy